TRABER PETER G has filed 7 insider transactions across 1 company since January 2023.
Most recent transaction: a sale of 705 shares of Cartesian Therapeutics, Inc. ($RNAC) on September 25, 2023.
Activity breakdown: 0 open-market purchases and 5 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 25, 2023 | Cartesian Therapeutics, Inc. | $RNAC | TRABER PETER G | Chief Medical Officer | S | Common Stock | 705 | $1.06 | 451,826.0000 | 5,101,459 | 0.16% | 0.01% |
| Jan. 4, 2023 | Cartesian Therapeutics, Inc. | $RNAC | TRABER PETER G | Chief Medical Officer | S | Common Stock | 8164 | $1.13 | 449,601.0000 | 5,101,459 | 1.78% | 0.16% |
| Jan. 4, 2023 | Cartesian Therapeutics, Inc. | $RNAC | TRABER PETER G | Chief Medical Officer | S | Common Stock | 15 | $1.14 | 449,586.0000 | 5,101,459 | 0.00% | 0.00% |
| Jan. 5, 2023 | Cartesian Therapeutics, Inc. | $RNAC | TRABER PETER G | Chief Medical Officer | S | Common Stock | 3445 | $1.13 | 446,141.0000 | 5,101,459 | 0.77% | 0.07% |
| Jan. 5, 2023 | Cartesian Therapeutics, Inc. | $RNAC | TRABER PETER G | Chief Medical Officer | S | Common Stock | 20 | $1.11 | 446,121.0000 | 5,101,459 | 0.00% | 0.00% |
| Jan. 2, 2023 | Cartesian Therapeutics, Inc. | $RNAC | TRABER PETER G | Chief Medical Officer | A | Common Stock | 200000 | $0.00 | 457,765.0000 | 5,101,459 | 77.59% | 3.92% |
| Jan. 2, 2023 | Cartesian Therapeutics, Inc. | $RNAC | TRABER PETER G | Chief Medical Officer | A | Employee Stock Option (right to buy) | 900000 | $0.00 | 900,000.0000 | 5,101,459 | 9999.99% | 17.64% |